Quantcast
Japan picks three COVID-19 drug candidates to get research funds - Metro US

Japan picks three COVID-19 drug candidates to get research funds

FILE PHOTO: A woman holds a medical syringe and a small bottle labelled "Coronavirus COVID-19 Vaccine

TOKYO (Reuters) – Japan has selected three candidates for COVID-19 treatments to receive subsidies for clinical trials, the health ministry said on Tuesday.

The drugs are AstraZeneca Plc’s antibody treatment AZD7442, Shionogi & Co’s protease inhibitor S-217622, and Fujifilm Holding Corp’s antiviral favipiravir, known commercially as Avigan.

(Reporting by Rocky Swift; Editing by Clarence Fernandez)

More from our Sister Sites